NCT02858466

Brief Summary

Neuropathic pain is a medical condition involving allodynia (painful perceptions in response to stimuli that normally are not) and spontaneous pain (occurring at rest, without stimulation). This pain is secondary to nervous system injury affecting the sensory system. The lesion is either at the nerve endings of the spinal cord or brain. It induces a loss of sensitivity and likely reorganization of brain activity that are causing pain and which are the subject of this study. Previous studies in functional neuroimaging has focused on brain areas activated during allodynic stimuli compared to non-painful stimuli. The abnormalities have been reported, but it was not possible to conclude formally. The authors failed to assess the part of the effect of the loss of sensory afferents (deafferentation) and the basal brain function. Indeed, the operation without any sensory stimulation is not known yet is the initial level of activity which is the benchmark for studying brain function during stimulation. The objective of this study is to understand what are the cortical systems of allodynic dysfunctional in patients compared with controls at baseline.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 25, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 8, 2016

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 22, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2019

Completed
Last Updated

September 28, 2020

Status Verified

September 1, 2020

Enrollment Period

3 years

First QC Date

July 25, 2016

Last Update Submit

September 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • cerebral blood flow

    quantified with MRI scan

    at baseline

Secondary Outcomes (4)

  • rate of grey matter

    at baseline

  • structure of the networks

    at baseline

  • connection of the networks

    at baseline

  • cortical loss

    at baseline

Study Arms (3)

peripheric nervous lesion

EXPERIMENTAL

MRI scan

Radiation: MRI scan

medullar or encephalic lesion

EXPERIMENTAL

MRI scan

Radiation: MRI scan

control group

OTHER

MRI scan

Radiation: MRI scan

Interventions

MRI scanRADIATION
control groupmedullar or encephalic lesionperipheric nervous lesion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • major
  • with nervous pain : chronic or peripheric
  • treatment not stable opioid since one week
  • signed consent
  • major
  • without chronic pain
  • signed consent

You may not qualify if:

  • severe psychiatric history
  • presence of an active nervous lesion
  • subject with morphine treatment
  • contraindication to MRI scan

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de SAINT-ETIENNE

Saint-Etienne, 42000, France

Location

MeSH Terms

Conditions

Neuralgia

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Roland PEYRON, MD

    CHU de SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2016

First Posted

August 8, 2016

Study Start

March 25, 2016

Primary Completion

March 22, 2019

Study Completion

March 22, 2019

Last Updated

September 28, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations